Aspo Plc
5.1.2026 17:30:00 CET | Globenewswire | Press release
Aspo Plc: Share repurchase 5.1.2026
Aspo Plc: Share repurchase 5.1.2026
| Aspo Plc | ANNOUNCEMENT | 5.1.2026 |
| Aspo Plc: Share repurchase 5.1.2026 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 5.1.2026 | |
| Bourse trade | Buy | |
| Share | ASPO | |
| Amount | 1 000 | Shares |
| Average price/ share | 7,0200 | EUR |
| Total cost | 7 020,00 | EUR |
| Aspo Plc now holds a total of 110 052 shares | ||
| including the shares repurchased on 5.1.2026 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Aspo Plc | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
| For more information, please contact: | ||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | ||
| www.aspo.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal Philips24.8.2026 23:04:56 CEST | Press release
Philips prices EU green bond for EUR 650M
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom